Sunday, July 27, 2025 2:00:59 PM
Exactly, the company has NOT said anything of substance for almost 600 days and yet there‘a like 50 new posts on a SUNDAY and 35 are bashers (who claim to not own shares) spouting pure FUD, and 10 are posts/reposts of AI generated “analysis” based almost entirely unproven breadcrumbs, with varying degrees of detachment from reality.
Meanwhile the company is SILENT and more than happy to let real shareholders rot in an information vacuum at .25 a share, while diluting almost 1 MILLION shares every single DAY, while expecting shareholders to counter the FUD (they literally had the nerve to ask us to do so).
There’s a term in law called “bad faith” that refers to intentional dishonest behavior, breach of trust, or a lack of good intentions during a transaction or interaction. It suggests that one party is not acting with the usual standards of honesty and fair dealing expected in such situations. There is a LOT of bad faith going around right now IMO, and it’s driving real shareholders (the only people who should be posting on this board) insane and none of it is actually helping the people that suffer from the worst disease on planet earth one bit.
Meanwhile the company is SILENT and more than happy to let real shareholders rot in an information vacuum at .25 a share, while diluting almost 1 MILLION shares every single DAY, while expecting shareholders to counter the FUD (they literally had the nerve to ask us to do so).
There’s a term in law called “bad faith” that refers to intentional dishonest behavior, breach of trust, or a lack of good intentions during a transaction or interaction. It suggests that one party is not acting with the usual standards of honesty and fair dealing expected in such situations. There is a LOT of bad faith going around right now IMO, and it’s driving real shareholders (the only people who should be posting on this board) insane and none of it is actually helping the people that suffer from the worst disease on planet earth one bit.
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
